Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Biomed Res Int ; 2022: 4338793, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35360518

RESUMO

Background: Minichromosome maintenance (MCM) genes are crucial for genomic DNA replication and are important biomarkers in tumor biology. In this study, we aimed to identify the diagnostic, therapeutic, and prognostic value of the MCM2-10 genes in patients with lung cancer. Methods: We examined the expression levels, gene networks, and protein networks of lung cancer using data from the ONCOMINE, GeneMANIA, and STRING databases. We conducted a functional enrichment analysis of MCM2-10 using the clusterProfiler package using TCGA data. The correlation between the MCM2-10 expression and lung cancer prognosis was evaluated using Cox regression analysis. The influence of clinical variables on overall survival (OS) was evaluated using univariate and multivariate analyses. The TIMER database was used to evaluate the correlation between tumor infiltrating levels and lung cancer. Kaplan-Meier Plotter pan-cancer RNA sequencing was used to estimate the correlation between the MCM5 expression and OS in different immune cell subgroups in patients with lung adenocarcinoma (LUAD). Finally, the 1-, 3-, and 5-year predictions of LUAD were performed using nomogram and calibration analysis. Results: The expression of MCM2, 3, 4, 5, 6, 7, 8, and 10 in lung cancer was higher than that for normal samples. The MCM5 expression was associated with poor OS in patients with LUAD, and prognosis was related to TNM stage, smoking status, and pathological stage. The MCM5 expression is correlated with immune invasion in LUAD and may affect prognosis due to immune infiltration. Conclusion: MCM5 may serve as a molecular biomarker for LUAD prognosis.


Assuntos
Adenocarcinoma de Pulmão , Neoplasias Pulmonares , Adenocarcinoma de Pulmão/patologia , Biomarcadores Tumorais/genética , Biomarcadores Tumorais/metabolismo , Proteínas de Ciclo Celular , Regulação Neoplásica da Expressão Gênica , Humanos , Neoplasias Pulmonares/patologia , Componente 5 do Complexo de Manutenção de Minicromossomo/metabolismo , Prognóstico
2.
Odontoestomatol ; 20(32): 78-83, diciembre de 2018.
Artigo em Inglês, Espanhol | LILACS, BNUY, BNUY-Odon | ID: biblio-968726

RESUMO

El objetivo de este estudio fue conocer la expresión de MCM4-5-6 en gérmenes dentarios humanos en estado de campana. Materiales y Métodos Se obtuvieron preparados histológicos de 4 maxilares fetales incluidos en parafina en el archivo de bloques de la cátedra de Histología de la Facultad de Odontología, UdelaR. Se procedió al corte de los mismos en secciones para técnica de rutina (HE) y de IHQ para MCM 4, 5 y 6. Resultados: Las diferentes regiones del órgano del esmalte mostraron 100 % de positividad en el estrato intermedio, una variación de 100 % a 0 % en el epitelio interno del órgano del esmalte, desde el sector cervical al sector incisal del mismo, y0% tanto en el retículo estrellado como en el epitelio externo del órgano del esmalte. Conclusiones: Los resultados obtenidos permitieron evidenciar y confirmar la acción proliferativa de las diferentes zonas del órgano del esmalte.


The aim of this study was to determine the expression of MCM4-5-6 in human tooth germs in the bell stage. Materials and methods: Histological samples were collected from four fetal maxillae placed in paraffin at the block archive of the Histology Department of the School of Dentistry, UdelaR. Sections were made for HE routine technique and for immunohistochemistry technique for MCM4-5-6. Results: Different regions of the enamel organ showed 100% positivity in the intermediate layer, a variation from 100% to 0% in the inner epithelium from the cervical loop to the incisal area, and 0% in the stellar reticulum as well as the outer epithelium. Conclusions: The results show and confirm the proliferative action of the different areas of the enamel organ.


Assuntos
Germe de Dente , Proliferação de Células , Componente 4 do Complexo de Manutenção de Minicromossomo , Componente 5 do Complexo de Manutenção de Minicromossomo , Componente 6 do Complexo de Manutenção de Minicromossomo
3.
J Proteome Res ; 15(7): 2178-86, 2016 07 01.
Artigo em Inglês | MEDLINE | ID: mdl-27239679

RESUMO

MYCN and HDAC2 jointly repress the transcription of tumor suppressive miR-183 in neuroblastoma. Enforced miR-183 expression induces neuroblastoma cell death and inhibits xenograft growth in mice. Here we aimed to focus more closely on the miR-183 signaling network using a label-free mass spectrometric approach. Analysis of neuroblastoma cells transfected with either control or miR-183 expression vectors identified 85 differentially expressed proteins. All six members of the minichromosome maintenance (MCM) complex, which is indispensable for initiation and elongation during DNA replication and transcriptionally activated by MYCN in neuroblastoma, emerged to be down-regulated by miR-183. Subsequent annotation category enrichment analysis revealed a ∼14-fold enrichment in the "MCM" protein module category, which highlighted this complex as a critical node in the miR-183 signaling network. Down-regulation was confirmed by Western blotting. MCMs 2-5 were predicted by in silico methods as direct miR-183 targets. Dual-luciferase reporter gene assays with 3'-UTR constructs of the randomly selected MCMs 3 and 5 experimentally confirmed them as direct targets of miR-183. Our results reveal the MCM complex to be a critical and directly regulated node within the miR-183 signaling network in MYCN-amplified neuroblastoma cells.


Assuntos
MicroRNAs/farmacologia , Proteínas de Manutenção de Minicromossomo/metabolismo , Proteína Proto-Oncogênica N-Myc/fisiologia , Neuroblastoma/patologia , Transdução de Sinais , Linhagem Celular Tumoral , Regulação para Baixo , Humanos , Espectrometria de Massas , MicroRNAs/metabolismo , Componente 3 do Complexo de Manutenção de Minicromossomo/efeitos dos fármacos , Componente 3 do Complexo de Manutenção de Minicromossomo/metabolismo , Componente 5 do Complexo de Manutenção de Minicromossomo/efeitos dos fármacos , Componente 5 do Complexo de Manutenção de Minicromossomo/metabolismo , Neuroblastoma/química , Neuroblastoma/metabolismo , Transfecção , Regulação para Cima
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...